Alissa Huston Porter, M.D.

Contact Information

Phone Numbers

Appointment: (585) 487-1700

Office: (585) 275-2778

A member of the University of Rochester Medical Faculty Group

An Accountable Health Partner

Accepting New Patients

Locations

125 Red Creek Dr, Ste 211
Calkins Corp Pk, Pluta Cancer Ctr
Rochester, NY 14623-4262

Surgical Oncology: (585) 487-1700

125 Red Creek Dr, Ste 101
Rochester, NY 14623-4262

Oncology: (585) 486-0600

Faculty Appointments

Associate Professor - Department of Medicine , Hematology/Oncology (SMD)

Patient Care Setting

Cancer

Biography

Alissa Huston is a Rochester native who received her medical degree at the University of Buffalo, and went on to complete an Internal Medicine residency at Strong Memorial Hospital. She then attended the University of Pittsburgh for her Hematology/Oncology fellowship, during which time she was involved in research involving bone metastasis in cancer. Currently, she is an Assistant Professor of Medicine at the James P. Wilmot Cancer Institute at the University of Rochester, where her clinical efforts are focused on breast cancer. She is also the Director for Medical Student and Resident Education for the Hematology/Oncology Division. Her research efforts focus on understanding the effects of treatment for breast cancer upon bone health, the role of vitamin D in breast cancer and how improvements in education affect residents and medical students rotating on our inpatient oncology unit. She is a member of the American Society of Clinical Oncology, the American Society of Breast Disease and the American Society for Bone and Mineral Research. Her philosophy is that there is no singular approach to patient care. Even though many patients may carry the same diagnosis, each individual is affected by that illness in a different way. Patients are not perceived as just a number, but instead approached and treated as the unique individuals they represent.

Credentials

Specialties

Hematology - American Board of Internal Medicine
Internal Medicine
Medical Oncology - American Board of Internal Medicine

Education

2000
MD | SUNY at Buffalo School of Medicine

Post-doctoral Training & Residency

07/01/2003 - 06/30/2006
Fellowship in Hematology/Oncology at University of Pittsburgh

06/30/2001 - 06/30/2003
Residency in Internal Medicine at University of Rochester Medical Center

06/30/2000 - 06/30/2001
Internship in Internal Medicine at University of Rochester Medical Center

VIEW ALL

Awards

2014
Jacob Gitelman Award
Sponsor: Gilda's Club of Rochester

2009 - 2011
Lawrence A. Kohn Senior Teaching Fellowship Award
Location: Department of Medicine, Strong Memorial Hospital

2005
ASH Clinical Research Training Institute (ASH-CRTI) Award. Phase I Trial of Perifosine and 17-DMAG in Patients with Relapsed/Ref

2005
ASCO/AACR Workshop Methods in Clinical Cancer Research Award. A Phase II Study Evaluating the Effects of COX-2 Inhibition on Lev

2004
Cancer Education Consortium Workshop Award: Clinical Pharmacology of Anticancer Agents

2000
AMWA Janet M. Glasgow Memorial Achievement Citation

1999
Induction into Alpha Omega Alpha Society

1997
James A. Gibson Anatomical Society Award

VIEW ALL

Clinical Trials

Prospective Validation Trial of Taxane Therapy (Docetaxel or Weekly Paclitaxel) and Risk of Chemotherapy-Induced Peripheral Neuropathy in African American Women

Lead Researcher: Alissa Huston

This phase II trial studies how well docetaxel or paclitaxel work in reducing chemotherapy-induced peripheral neuropathy in African American patients with stages I-III breast cancer. Drugs used in chemotherapy, such as docetaxel and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving docetaxel or paclitaxel may work better than other methods in reducing chemotherapy-induced peripheral neuropathy in patients with breast cancer.

View Study Details

Publications

Journal Articles

4/24/2020
Lei W, Duan R, Li J, Liu X, Huston A, Boyce BF, Yao Z. "The IAP Antagonist SM-164 Eliminates Triple-Negative Breast Cancer Metastasis to Bone and Lung in Mice." Scientific reports.. 2020 Apr 24; 10(1):7004. Epub 2020 Apr 24.

8/2018
Peppone LJ, Ling M, Huston AJ, Reid ME, Janelsins MC, Puzas JE, Kamen C, Del Giglio A, Asare M, Peoples AR, Mustian KM. "The effects of high-dose calcitriol and individualized exercise on bone metabolism in breast cancer survivors on hormonal therapy: a phase II feasibility trial." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2018 Aug 0; 26(8):2675-2683. Epub 2018 Feb 22.

1/15/2018
Williams AM, Shah R, Shayne M, Huston AJ, Krebs M, Murray N, Thompson BD, Doyle K, Korotkin J, van Wijngaarden E, Hyland S, Moynihan JA, Cory-Slechta DA, Janelsins MC. "Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy." Journal of neuroimmunology.. 2018 Jan 15; 314:17-23. Epub 2017 Oct 18.

Books & Chapters

2007
Chapter Title: Myeloma Bone Disease
Book Title: Translational Therapeutic Strategies in Multiple Myeloma
Author List: A. Huston and G. D. Roodman
Edited By: I. M. Ghobrial and K. Anderson
Published By: Informa Healthcare, Inc. 2007

2007
Chapter Title: Skeletal Complications: Bone Metabolism and Novel Targeted Agents
Book Title: Cancer Supportive Care: Advances in Therapeutic Strategies
Author List: A. Huston
Edited By: G. H. Lyman and J. Crawford
Published By: Informa healthcare, Inc. 2007

VIEW ALL PUBLICATIONS